Article Text

other Versions

PDF
Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiologic study in Italy
  1. Adriano Chiò (achio{at}usa.net)
  1. Department of Neuroscience, University of Torino, Italy
    1. Dario Cocito (dariococito{at}yahoo.it)
    1. Department of Neuroscience, University of Torino, Italy
      1. Edo Bottacchi (bottacchi.edo{at}uslaosta.com)
      1. Department of Neurology, Ospedale Regionale di Aosta, Italy
        1. Carlo Buffa (carlobuffa{at}tiscalinet.it)
        1. Department of Neurology, Ospedale Maria Vittoria, Torino, Italy
          1. Maurizio Leone (maurizio.leone{at}maggioreosp.novara.it)
          1. Department of Neurology, Università del Piemonte Orientale, Novara, Italy
            1. Federica Plano (kicca1976{at}yahoo.it)
            1. Department of Neuroscience, University of Torino, Italy
              1. Roberto Mutani (roberto.mutani{at}unito.it)
              1. Department of Neuroscience, University of Torino, Italy
                1. Andrea Calvo (adreacalvo{at}hotmail.com)
                1. Department of Neuroscience, University of Torino, Italy

                  Abstract

                  Background: The epidemiological characteristics of chronic inflammatory demyelinating polyneuropathy (CIDP) are still not fully understood.

                  Methods: The clinical and epidemiological characteristics of CIDP in an Italian population were assessed. All subjects with a diagnosis of demyelinating neuropathy after 1990 in Piemonte and Valle d’Aosta (4,334,225 inhabitants) were considered. The diagnosis of CIDP was based on the AAN research criteria.

                  Results: One hundred and sixty-five out of the 294 patients found met the diagnostic criteria. The crude prevalence rate was 3.58/100,000 population (95% CI 3.02 to 4.20). At the prevalence day, 76 (49.0%) cases had a definite, 67 (43.2%) a probable, and 12 (7.7%) a possible CIDP; the disability was mild in 105 (67.7%) cases, moderate in 32 (20.6%), and severe in 18 (11.6%). The course was remitting-relapsing in 40 cases (25.8%), chronic progressive in 96 (61.9%), and monophasic in 19 (12.3%). Considering the 95 patients whose disorder presented in the 1995-2001 period, the mean annual crude incidence rate was 0.36/100,000 population (95% CI 0.29 to 0.44), with a men to women rate ratio of 2.3:1. Fourteen cases were affected by diabetes mellitus. In multivariate analysis, factors related to severe disability at the prevalence day were: age>60 years; failure of immunomodulating therapies at the time of diagnosis; worse disability at nadir; and chronic course.

                  Conclusion: Incidence and prevalence rates of CIDP in Italy are higher than those observed in most previous studies. At prevalence day more than 80% of cases had a mild or moderate disability, indicating either a good response to immunomodulating therapy or a tendency of CIDP to have a mild course in most cases.

                  • CIDP
                  • incidence
                  • prevalence
                  • prognosis

                  Statistics from Altmetric.com

                  Request permissions

                  If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.